Production (Stage)
Tango Therapeutics, Inc.
TNGX
$1.84
-$0.025-1.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 216.72M | 257.92M | 293.28M | 322.11M | 343.60M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.78M | 8.43M | 7.54M | 6.30M | 8.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 428.00K | -- | -- | -- | -- |
| Total Current Assets | 224.93M | 266.34M | 300.82M | 328.41M | 352.04M |
|
|
|||||
| Total Current Assets | 224.93M | 266.34M | 300.82M | 328.41M | 352.04M |
| Net Property, Plant & Equipment | 47.24M | 47.58M | 49.02M | 50.47M | 51.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.14M | 2.57M | 2.58M | 2.58M | 2.58M |
| Total Assets | 274.31M | 316.49M | 352.42M | 381.45M | 406.22M |
|
|
|||||
| Total Accounts Payable | 3.24M | 1.60M | 4.11M | 1.06M | 3.90M |
| Total Accrued Expenses | 8.40M | 14.76M | 12.26M | 15.26M | 11.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.82M | 2.45M | 2.86M | 2.36M | 2.07M |
| Total Finance Division Other Current Liabilities | 21.46M | 19.35M | 18.35M | 25.18M | 25.06M |
| Total Other Current Liabilities | 21.46M | 19.35M | 18.35M | 25.18M | 25.06M |
| Total Current Liabilities | 35.92M | 38.17M | 37.58M | 43.87M | 42.79M |
|
|
|||||
| Total Current Liabilities | 35.92M | 38.17M | 37.58M | 43.87M | 42.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 34.12M | 34.04M | 34.76M | 35.47M | 36.17M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.51M | 44.77M | 50.90M | 54.44M | 62.81M |
| Total Liabilities | 107.55M | 116.98M | 123.25M | 133.78M | 141.77M |
|
|
|||||
| Common Stock & APIC | 708.00M | 700.74M | 692.31M | 682.73M | 673.88M |
| Retained Earnings | -541.43M | -501.56M | -463.89M | -434.72M | -409.17M |
| Treasury Stock & Other | 194.00K | 336.00K | 750.00K | -334.00K | -257.00K |
| Total Common Equity | 166.76M | 199.52M | 229.17M | 247.67M | 264.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 166.76M | 199.52M | 229.17M | 247.67M | 264.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 166.76M | 199.52M | 229.17M | 247.67M | 264.45M |
|
|
|||||